PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
April 26, 2026BMC Infectious Diseases0 citationsOpen Access

Bronchobiliary fistula secondary to hepatic malignancy with Exophiala dermatitidis infection: a case report

HSHaizhen SuYZY ZhangQZQianYing Zhu

Key Points

  • This report investigates the correlation between bronchobiliary fistula and Exophiala dermatitidis infections following hepatic malignancy treatment.
  • Patient presented with fever and dyspnoea after hepatic malignancy treatment.
  • Bronchoscopy and imaging evaluated bronchobiliary fistula, hepatic, and subphrenic abscesses.
  • Cultures from abscess and bronchoalveolar lavage fluid identified Exophiala dermatitidis.
  • Patient treated with voriconazole and drainage showed symptom remission.
  • After five months, the patient experienced disease recurrence, leading to readmission.
  • Importance of microbiological evaluation for patients with hepatic infections complicated by pulmonary issues was underscored.

Abstract

Bronchobiliary fistula (BBF) is a rare but severe complication following the treatment of hepatic malignancies. Exophiala Dermatitidis(E. Dermatitidis), a dematiaceous fungus, is an opportunistic pathogen that predominantly affects immunocompromised individuals. However, its role in BBF-associated infections has not been previously documented. A 79-year-old man who was diagnosed with metastatic hepatic malignancy three years prior presented with a fever that persisted for seven days and dyspnoea for two days; a comprehensive evaluation was initiated on admission. Bronchoscopy revealed the presence of BBF, and imaging revealed hepatic and subphrenic abscesses. Ultrasound-guided drainage of the hepatic abscess was performed, and both the abscess aspirate and bronchoalveolar lavage fluid yielded E. dermatitidis on culture. Based on the clinical and microbiological findings, a diagnosis of BBF-related E. dermatitidis infection was established. The patient was treated with voriconazole (VRCZ) in conjunction with drainage. Antimicrobial therapy achieved the remission of symptoms, and the patient was discharged. Five months later, the disease recurred, necessitating readmission. Given the end-stage malignancy, profoundly poor performance status, and dismal prognosis, after exhaustive discussion, the family opted to forgo further active treatment. This case highlights for the first time that BBF may serve as a unique conduit for the dissemination of E. dermatitidis, underscoring the importance of considering rare pathogens in patients with hepatic abscesses complicated by pulmonary infections. A prompt microbiological evaluation and targeted antifungal therapy are essential for optimal outcomes. This article is a case report; therefore, I declare that a clinical trial number is not applicable.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Su et al. (2026) studied this question.

synapsesocial.com/papers/69edabb84a46254e215b388bhttps://doi.org/10.1186/s12879-026-13392-6
Ask AI
Helpful
Bookmark
Share
View Full Paper